Autoinjectors Market to hit USD 186 billion by 2032, says Global Market Insights Inc.
February 01, 2023 03:10 ET | Global Market Insights Inc.
Selbyville, Delaware, Feb. 01, 2023 (GLOBE NEWSWIRE) -- The autoinjectors market value is poised to exceed USD 186 billion by 2032, according to a new research report by Global Market Insights...
Global Companion Animal Arthritis Market Expected to Garner $5,520.5 Million in the 2022-2031 Timeframe, Growing at 7.0% CAGR [250-Pages] | Released by Research Dive
January 23, 2023 09:03 ET | Research Dive
New York, USA, Jan. 23, 2023 (GLOBE NEWSWIRE) -- According to the latest report published by Research Dive, the global companion animal arthritis market is predicted to rise at a tremendous CAGR of...
Palmetto Infusion's Panama City, Florida, clinic
Palmetto Infusion, leading infusion provider in southeast, opens first clinic in Florida
December 05, 2022 10:23 ET | Palmetto Infusion
Panama City, Florida, Dec. 05, 2022 (GLOBE NEWSWIRE) -- Palmetto Infusion, the leading ambulatory infusion provider in the southeast, today announces a new clinic opening in Panama City—the first in...
Exagen Announces Appointment of Andrew L. Concoff MD, FACR, CAQSM, as Chief Innovation Officer
October 04, 2022 08:25 ET | Exagen Inc.
SAN DIEGO, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced the appointment of Andrew L. Concoff M.D. FACR, CAQSM as...
Arthroscopy Devices Market Worth $9.85Bn, Globally, by 2028 at 8.1% CAGR - Exclusive Report by The Insight Partners
May 23, 2022 08:44 ET | The Insight Partners
New York, May 23, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Arthroscopy Devices Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product...
Biosimilars in Immunology Prescriber Opinions Survey 2021 - Factors Influencing Choice of Prescribed Biosimilar Brands
January 20, 2022 05:58 ET | Research and Markets
Dublin, Jan. 20, 2022 (GLOBE NEWSWIRE) -- The "Prescriber Opinions on Biosimilars in Immunology" report has been added to's offering. This report covers the 7MM (United...
Exagen logo_440x386 (1).jpg
Exagen Inc. and Queen Mary University of London Announce Exclusive License and Collaboration to Develop Novel Patented Molecular Signatures for Rheumatoid Arthritis Biologic Therapeutic Selection
January 09, 2022 12:00 ET | Exagen Inc.
SAN DIEGO, Jan. 09, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, and Queen Mary University of London, announced today the execution of a...
Coherus BioSciences, Inc. logo
Coherus Announces U.S. FDA Approval of YUSIMRY™ (adalimumab-aqvh)
December 20, 2021 07:59 ET | Coherus BioSciences, Inc.
- Approved for all eligible indications of the reference biological product, Humira® (adalimumab) - - YUSIMRY is Coherus' second FDA-approved product - REDWOOD CITY, Calif., Dec. 20, 2021 (GLOBE...
Exagen logo_440x386 (1).jpg
Exagen Inc. Reports Third Quarter 2021 Results
November 10, 2021 16:05 ET | Exagen Inc.
SAN DIEGO, Nov. 10, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended September 30, 2021....
SetPoint Medical Appoints Amy Derosier as Vice President of Clinical Affairs
November 03, 2021 09:00 ET | SetPoint Medical
VALENCIA, Calif., Nov. 03, 2021 (GLOBE NEWSWIRE) -- SetPoint Medical, a clinical-stage bioelectronic medicine company developing therapies for chronic autoimmune diseases, today announced the...